Saami K. Yazdani, PhD

Original Contribution

Preclinical Evaluation of Second-Generation Everolimus- and Zotarolimus-Eluting Coronary Stents

07/30/2013

Saami K. Yazdani , PhD;

Alexander Sheehy ;

Marc Vorpahl , MD;

Masataka Nakano , MD;

Fumiyuki Otsuka , MD, PhD;

Gaku Nakazawa , MD;

Charles A. Simonton III, MD;

Rosy S. Donn ;

Laura E. Perkins , DVM, PhD;

Renu Virmani , MD, PhD;

Frank D. Kolodgie , PhD;

Second-generation DES have alleviated the safety concerns of late stent thrombosis by addressing issues of polymer biocompatibility, stent design and optimizing drug loads and release kinetics. This study was designed to evaluate the...

Second-generation DES have...

07/30/2013

Journal of Invasive Cardiology

New Techniques

Occlusion Perfusion Catheter (OPC): A Universal Drug-Delivery Device--Next Generation

09/10/2017

Saami K. Yazdani , PhD;

Rex Teeslink , MD;

The authors present the Occlusion Perfusion catheter (OPC), a universal drug-delivery device. This catheter allows for delivery of antiproliferative drug to a targeted treatment area, demonstrates exceptional medial layer drug uptake, and can...

The authors present the...

09/10/2017

Vascular Disease Management